Featured Article
Precision Oncology Today
Magazine
Fully Exposed: Understanding the Exposome Can Drive the Future of Health and Wellness
The field of exposomics is still in its early stages. Pioneering researchers are grappling with methods to marry multi-omic datasets, blood and urine mass spectrometry data, and even postal code and satellite data to gain insights into the highly complex interface between human biology and environmental exposures--and how it affects human health and wellness.
In Conversation with Michelle Werner
Inside Precision Medicine’s editor in chief, Damian Doherty, spoke to Werner, Alltrna's CEO, about her career, her motivation to lead this company, and what rare disease means to her on a personal level.
Trending on Inside Precision Medicine
Genetic Variant Identified Responsible for Higher Risk of ALL in Latinos
Research from investigators at the Keck School of Medicine of USC has identified a key genetic variant that contributes to the increased risk of developing acute lymphoblastic leukemia among children of Hispanic/Latino origin.
Cancer Drug Part of New Combination Therapy Targeting TB
Researchers have devised a host-directed therapy (HDT) approach to targeting TB, which uses the anticancer drug bevacizumab in combination with losartan, to improve blood flow within granulomas and normalize the extracellular matrix (ECM).
New Atlas of Rare Stem and Progenitor Cells Reveals New Cell Types
Researchers have developed a new atlas of rare hematopoietic stem and progenitor cells, those cells that trigger production of mature blood cells.